Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 15% compared to the benchmark index [4]. Core Insights - The company reported a revenue of 5.051 billion yuan for 2025, representing a year-on-year growth of 30%, with a net profit attributable to the parent company of 1.204 billion yuan, up 36.73% year-on-year [1]. - The company's gross margin for 2025 was 84.22%, a slight decrease of 0.15 percentage points, while the net margin improved by 1.18 percentage points to 23.87% [1]. - The company has seen significant growth in both offline and online sales channels, with offline sales reaching 2.426 billion yuan (up 24.49% year-on-year) and online sales at 2.477 billion yuan (up 38.83% year-on-year) [3]. Revenue and Profitability - In 2025, the cosmetics segment generated 2.996 billion yuan in revenue, a growth of 30.04%, while the skincare segment achieved 1.873 billion yuan, growing by 31.08% [2]. - The average selling price for cosmetics was 176.4 yuan, and for skincare, it was 328.3 yuan, showing slight changes from the previous year [2]. - The company expects net profits to reach 1.583 billion yuan in 2026, 2.041 billion yuan in 2027, and 2.583 billion yuan in 2028, with corresponding P/E ratios of 20, 16, and 12 times [4][6]. Market Expansion - The company has expanded its offline presence with 412 self-operated counters and 33 distributor counters, marking an increase in average revenue per comparable self-operated counter to 5.6 million yuan [3]. - The company opened its first overseas self-operated counter in Hong Kong, indicating ongoing globalization efforts [3]. - The overall repurchase rate for the company's membership system reached 33.3%, an increase of 2.4 percentage points year-on-year [3].

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance relative to the market index [4]. Core Insights - The company achieved a revenue of 5.05 billion RMB in 2025, representing a year-over-year growth of 30.0%, with a net profit of 1.21 billion RMB, up 36.8% year-over-year [1]. - The growth in revenue and net profit is attributed to the successful performance of major product categories, including cosmetics and skincare, with several products exceeding 1 billion RMB in sales [7]. - The company is expected to continue its growth trajectory, with projected net profits of 1.59 billion RMB, 1.99 billion RMB, and 2.42 billion RMB for 2026, 2027, and 2028, respectively, reflecting growth rates of 32%, 25%, and 22% [7]. Revenue Breakdown - **Cosmetics**: In 2025, revenue reached 3.0 billion RMB, with a year-over-year growth of 30.0%. The average selling price decreased by 1%, while the volume increased by 31% [2]. - **Skincare**: Revenue for skincare products was 1.87 billion RMB, growing by 31.1% year-over-year, with significant contributions from star products [2]. - **Fragrance**: The fragrance segment generated 34 million RMB in its first year, indicating potential for brand development [2]. - **Training Business**: This segment saw a slight decline, with revenue of 150 million RMB, down 2.8% year-over-year [2]. Channel Performance - **Online Channels**: Revenue from online sales was 2.48 billion RMB, reflecting a year-over-year increase of 38.8%, with a customer repurchase rate of 30.3% [6]. - **Offline Channels**: Offline sales reached 2.43 billion RMB, up 24.5% year-over-year, with a repurchase rate of 36.5% [6]. Financial Metrics - The company’s gross margin for 2025 was 84.2%, with a net profit margin of 23.9%, indicating stable profitability [6]. - The projected earnings per share (EPS) for 2026 is 3.24 RMB, with a price-to-earnings (P/E) ratio of 21.14 [8].

Summary of the Conference Call for Mao Geping Company Company Overview - **Company**: Mao Geping - **Industry**: Cosmetics and Skincare Key Financial Performance and Profitability - **2025 Revenue**: 50.5 billion CNY, a year-on-year increase of 30% [3] - **Net Profit**: 12.1 billion CNY, a year-on-year increase of 37% [3] - **Net Profit Margin**: Increased by 1.2 percentage points to 23.9% [3] - **Gross Margin**: 84.2%, a slight decrease of 0.2 percentage points from 2024 [3] - **Gross Margin by Category**: Skincare at 87.3%, Makeup at 83.3% [3] - **Sales Expense Ratio**: 48.3%, down by 0.7 percentage points [3] - **Management Expense Ratio**: 5.3%, down by 1.6 percentage points [3] Revenue Breakdown by Category - **Makeup Revenue**: 30 billion CNY, a year-on-year increase of 30%, accounting for 59% of total revenue [4] - **Top Products**: Caviar Cushion (over 5 billion CNY), Gold Fan Powder, Skin Garment (both over 3 billion CNY) [4] - **Skincare Revenue**: 18.7 billion CNY, a year-on-year increase of 31%, accounting for 37% of total revenue [4] - **Top Products**: Luxury Caviar Mask (over 10 billion CNY), Black Cream (over 4 billion CNY), Caviar Eye Mask (around 1 billion CNY) [4] - **Fragrance Revenue**: New category launched in May 2025, contributing approximately 34 million CNY by year-end [4] Channel Performance - **Online Revenue**: 24.8 billion CNY, a year-on-year increase of 39%, with a net profit margin of 26.2% [5] - **Offline Revenue**: 24.3 billion CNY, a year-on-year increase of 24.5%, with a net profit margin of 21.6% [5] - **Store Expansion**: 36 new offline stores added in 2025, with same-store sales growth of 16% [5] - **Customer Retention**: Repeat purchase rate increased to 36.5% [5] Future Growth Guidance - **2026 Revenue Target**: Maintain over 30% growth, with net profit growth slightly exceeding revenue growth [6] - **Makeup Strategy**: Focus on core products and new launches, with significant growth potential in color cosmetics [6] - **Skincare Focus**: Emphasis on daily skincare lines, with six major series launched [7] - **Fragrance Strategy**: Plans to expand in the domestic perfume market, leveraging brand storytelling [7] Expansion Plans - **Offline Store Growth**: Plan to add approximately 30 new stores in 2026, focusing on high-end malls and airports [8] - **Same-Store Growth Target**: Maintain at least 12% growth [8] - **International Expansion**: Targeting top luxury malls abroad, leveraging partnerships for high-end retail access [8] Valuation and Market Outlook - **2026 Net Profit Estimate**: Approximately 16 billion CNY, corresponding to a PE ratio of about 19 times [9] - **Investment Thesis**: Considered a high-end domestic brand with attractive valuation and growth potential [9]

Investment Rating - The report maintains an "Outperform" rating for Mao Geping Cosmetics [2][3]. Core Insights - The company achieved a revenue of RMB 5.05 billion in 2025, reflecting a year-on-year growth of 30%, and net profit attributable to the parent was RMB 1.20 billion, up 36.7% year-on-year [4][12]. - Management has set a growth guidance of 30% for the upcoming years, with expectations for revenue to reach RMB 6.50 billion, RMB 8.15 billion, and RMB 9.97 billion in 2026, 2027, and 2028, respectively [3][11]. - The company’s net profit margins are projected to remain robust at 23.3%, 22.9%, and 22.7% for the years 2026 to 2028 [11]. Financial Performance - Revenue for 2025 was RMB 5.05 billion, slightly below expectations by 1.0%, while net profit exceeded expectations by 0.2% [4][12]. - The gross profit margin for 2025 was reported at 84.2%, which is an improvement of 0.3 percentage points compared to expectations [8]. - The company’s diluted EPS for 2025 was RMB 2.46, with a projected increase to RMB 3.09 in 2026 [2][10]. Product Performance - Key products such as the Luxury Caviar Cushion and the Luxury Caviar Mask have shown strong sales, contributing significantly to revenue [5][13]. - The color cosmetics segment generated RMB 3.00 billion in revenue for 2025, while skincare revenue reached RMB 1.87 billion, both showing substantial year-on-year growth [14][15]. - New product launches in 2026 are expected to further enhance sales, particularly in the skincare and eye makeup categories [5][13]. Market Position and Strategy - The company has successfully increased its online sales, which accounted for over 50% of total revenue for the first time, with a year-on-year growth of 38.8% [6][15]. - Offline same-store sales grew by 16%, indicating strong brand loyalty and customer retention [6][15]. - Mao Geping Cosmetics aims to continue expanding its high-end market presence while maintaining a clear strategy focused on online customer acquisition and premium product offerings [14][15].

Investment Rating - The report maintains an "Outperform" rating for Mao Geping Cosmetics [2][3]. Core Insights - The company achieved a revenue of RMB 5.05 billion in 2025, reflecting a year-on-year growth of 30%, and net profit attributable to the parent was RMB 1.20 billion, up 36.7% year-on-year [4][12]. - Management has set a growth guidance of 30% for the upcoming years, with expectations for revenue to reach RMB 6.50 billion, RMB 8.15 billion, and RMB 9.97 billion in 2026, 2027, and 2028, respectively [3][11]. - The company has demonstrated strong performance in its core product lines, with significant contributions from new product launches in both color cosmetics and skincare [5][13]. Financial Performance - For 2025, the company reported a gross profit margin of 84.2% and a net profit margin of 23.8% [4][12]. - The projected net profit for 2026 is RMB 1.52 billion, with a net profit margin of 23.3%, and is expected to grow at a rate of 25.8% year-on-year [3][11]. - The company’s revenue growth is expected to slow slightly to 28.7% in 2026, 25.4% in 2027, and 22.4% in 2028 [3][11]. Product Performance - Key products such as the Luxury Caviar Cushion and the Luxury Caviar Mask have shown strong sales, contributing significantly to the overall revenue [5][13]. - The color cosmetics segment generated RMB 3.00 billion in revenue for 2025, while skincare revenue reached RMB 1.87 billion, indicating robust growth in both categories [14][15]. Market Position and Strategy - The company has successfully increased its online sales, which accounted for over 50% of total revenue for the first time, with a year-on-year growth of 38.8% [6][15]. - Mao Geping Cosmetics plans to continue expanding its high-end product lines and enhance its online presence to attract more customers [5][14].

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Views - The report highlights a significant performance disclosure period for listed companies, focusing on high-growth sectors such as gold and jewelry, cosmetics, and medical aesthetics, with a notable divergence in performance among consumer brands [4][25] - High-end domestic brands like Laopuhuangjin and Maogeping are showing strong growth, while brands that adapt to channel changes and possess differentiated product capabilities, such as Chaohongji and Shangmei, are also performing well [4][25] Summary by Sections Retail and Social Services Market Review - The retail and social services indices reported declines of 1.10% and 1.52% respectively during the week of March 23-27, 2026, ranking 19th and 24th among 31 primary industries [6][14] - The jewelry sector saw the highest weekly increase of 1.05%, while the hotel and restaurant sector led year-to-date performance with a 0.77% increase [18][20] Industry Dynamics - The report emphasizes the ongoing annual report disclosures from listed companies, with a focus on high-growth companies [25] - The gold and jewelry sector continues to show a trend towards high-end and fashionable products, with Laopuhuangjin and Chaohongji demonstrating exceptional performance [28][39] Investment Recommendations - Investment focus areas include: - Gold and jewelry brands with differentiated product capabilities, recommending Laopuhuangjin, Chaohongji, and Zhou Dafu [7][42] - Offline retail companies adapting to trends and AI-enabled cross-border e-commerce leaders, recommending Yonghui Supermarket and Jihong Co [7][39] - Cosmetics brands that meet emotional value and safety innovation, recommending Maogeping, Shangmei, and Beitaini [7][40] - Medical aesthetics firms with differentiated products and expanding chains, recommending Aimeike and Meilitiantian Medical Health [7][41] Company-Specific Insights - Laopuhuangjin reported a revenue of 27.303 billion yuan (+221.0%) and a net profit of 4.868 billion yuan (+230.5%) for FY2025, with expectations for continued growth in Q1 2026 [28][41] - Chaohongji achieved a revenue of 9.318 billion yuan (+43.0%) and a net profit of 497 million yuan (+156.7%) for FY2025, with rapid growth in its franchise business [45][46] - Maogeping's revenue reached 5.050 billion yuan (+30.0%) with a net profit of 1.205 billion yuan (+36.8%) for FY2025, showcasing strong performance in high-end channels [32][41] - Shangmei reported a revenue of 9.178 billion yuan (+35.1%) and a net profit of 1.103 billion yuan (+41.1%) for FY2025, with a focus on multi-category growth [32][41]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][11] Core Insights - The company reported a revenue increase of 30.0% year-on-year for 2025, reaching 5.05 billion yuan, and a net profit increase of 36.8%, amounting to 1.205 billion yuan. The brand's momentum continues to be strong, leading to an upward revision of profit forecasts for 2026-2028 [4][5] - The company expects net profits for 2026, 2027, and 2028 to be 1.587 billion, 1.978 billion, and 2.457 billion yuan respectively, with corresponding EPS of 3.24, 4.04, and 5.01 yuan. The current stock price corresponds to P/E ratios of 19.0, 15.2, and 12.2 for the respective years [4][7] Financial Performance - In 2025, the company's revenue from different segments was as follows: makeup 2.996 billion yuan (up 30.0%), skincare 1.873 billion yuan (up 31.1%), and training 147 million yuan (down 2.8%). The newly added fragrance segment generated 34 million yuan [5] - The online and offline channels generated revenues of 2.477 billion and 2.426 billion yuan respectively, with year-on-year growth of 38.8% and 24.5% [5] - The gross profit margin for 2025 was 84.2%, with slight decreases in various segments, while the overall expense ratios for sales and management showed a steady decline [5][7] Business Development - The company continues to strengthen its high-end positioning with successful product launches in the makeup and skincare segments, including significant sales from key products [6] - The company has expanded its presence in high-end retail locations and online platforms, achieving notable sales growth in e-commerce channels [6]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][11] Core Insights - The company reported a revenue increase of 30.0% year-on-year for 2025, reaching 5.05 billion yuan, and a net profit increase of 36.8%, amounting to 1.205 billion yuan. The brand's momentum continues to be strong, leading to an upward revision of profit forecasts for 2026-2028 [4][5] - The company expects net profits for 2026, 2027, and 2028 to be 1.587 billion, 1.978 billion, and 2.457 billion yuan respectively, with corresponding EPS of 3.24, 4.04, and 5.01 yuan. The current stock price corresponds to P/E ratios of 19.0, 15.2, and 12.2 for the respective years [4][7] Financial Performance - In 2025, the revenue breakdown by business segment was as follows: makeup 2.996 billion yuan (up 30.0%), skincare 1.873 billion yuan (up 31.1%), and makeup training 147 million yuan (down 2.8%). The newly added fragrance segment generated 34 million yuan [5] - Revenue from online and offline channels reached 2.477 billion and 2.426 billion yuan respectively, with year-on-year growth of 38.8% and 24.5% [5] - The gross margin for 2025 was 84.2%, with slight decreases in various segments, while the overall expense ratios for sales and management decreased to 48.3% and 5.3% respectively [5] Business Development - The company has solidified its leading position in high-end domestic makeup, with significant sales from key products such as the small gold fan powder and caviar cushion, each exceeding 300 million yuan. The skincare segment also saw strong performance with flagship products achieving over 1 billion yuan in retail sales [6] - The company is expanding its high-end channel presence and has opened new stores in prestigious locations, enhancing its brand positioning. The online sales channels are also performing well, with significant growth expected to continue [6]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The retail industry is undergoing an evolution in the "people, goods, and scene" framework, driven by emotional consumption, which presents new opportunities for growth [3][25] - High-end gold and fashion jewelry are gaining traction among consumers, with a focus on product differentiation and cultural significance [3][32] - The cosmetics industry is innovating through the IP of technical ingredients and cultural confidence, enhancing product appeal and market competitiveness [3][37] - Offline retail is shifting from selling "goods" to offering "services and experiences," with companies like Yonghui Supermarket leading the transformation [3][41] Summary by Sections Retail Market Overview - In 2025, the retail sector index closed at 2422.59 points, with an annual increase of 8.21%, underperforming the Shanghai Composite Index, which rose by 18.41% [5][14] - The retail industry ranked 23rd among 31 sectors in terms of performance [15] Industry Dynamics - The emotional value is driving consumer intentions, with a focus on "research-based consumption," "self-satisfaction," and "long-termism" as key decision-making trends [25][28] - High-end gold is becoming a preferred asset for wealth preservation, while fashion gold is appealing to younger consumers through innovative designs and social media engagement [32] - The cosmetics sector is witnessing a shift towards self-developed core ingredients and cultural narratives, enhancing brand value [37] Investment Recommendations - Focus on high-quality companies in the emotional consumption theme, particularly in the gold jewelry sector, with recommendations for brands like Chao Hong Ji and Lao Pu Gold [6][50] - Emphasize offline retail companies adapting to market changes, such as Yonghui Supermarket and Ai Ying Shi [6][48] - Highlight cosmetics brands that innovate in emotional value and safety, including Mao Ge Ping and Po Lai Ya [6][48] - Consider differentiated medical beauty product manufacturers and leading medical beauty institutions, recommending companies like Ai Mei Ke and Ke Di-B [6][48]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Views - The retail industry is experiencing a transformation with a focus on emotional consumption and innovative product offerings, particularly in the jewelry and cosmetics sectors [6][33] - Companies like潮宏基 and毛戈平 are leveraging multi-channel strategies to enhance brand visibility and product sales, indicating a strong market presence [26][31] Summary by Sections Retail Market Overview - The retail index closed at 2462.73 points, with a weekly increase of 0.16%, underperforming the Shanghai Composite Index, which rose by 1.88% [5][15] - The retail sector has seen a year-to-date increase of 10.00%, lagging behind the Shanghai Composite Index's 18.26% rise [15][19] Company Highlights - **潮宏基**: Achieved a revenue of 62.37 billion yuan in the first three quarters of 2025, up 28.4% year-on-year, with a net profit of 3.17 billion yuan, reflecting a 0.3% increase [42] - **毛戈平**: Launched the "琉光赋活" skincare series, set to debut on January 1, 2026, focusing on high-end skincare needs [31] - **周大福**: Reported a revenue of 389.86 billion HKD for FY2026H1, a slight decrease of 1.1%, but with a net profit increase of 0.1% [39] Investment Themes - **Gold and Jewelry**: Focus on brands with differentiated product offerings and consumer insights, recommending潮宏基 and老铺黄金 as key players [6][33] - **Offline Retail**: Emphasis on companies adapting to market changes, with recommendations for永辉超市 and爱婴室 [6][33] - **Cosmetics**: Highlighting brands that innovate with emotional value and safe ingredients, recommending毛戈平 and珀莱雅 [6][34] - **Medical Aesthetics**: Targeting differentiated product manufacturers and expanding medical aesthetic chains, with recommendations for爱美客 and科笛-B [6][34]